Decreased Levels of Adenylate Cyclase Contribute to the Down-Regulation of Beta-Adrenergic Signal Transduction in the Salivary Glands of the Non-Obese Diabetic (NOD) Mouse

References

• Gottlieb P. A., Rossini A. A., Mordes J. P. Approaches to prevention and treatment of IDDM in animal models. Diabetes Care 1988; 11(Suppl.1)29–36
   Google Scholar
• Yamada K., Hanafusa T., Fujino-Kurihara H., Miyazaki A., Nakajima H., Miyagawa J., Kono N., Nonaka K., Tarui S. Nicotinamide prevents lymphocytie infiltration in submandibular glands but not the appearance of antisalivary duct antibodies in non-obese diabetic (NOD) mice. Res. Commun. Chem. Pathol. Pharmacol. 1985; 50: 83–91
   Google Scholar
• Asamoto H., Oishi M., Akazawa Y., Tochino Y. Histologic and immunologic changes in the thymus and other organs in NOD mice. Insulitis and Type I Diabetes, T. Seiichiro, T. Tochino, K. Noraka. Academic Press, Tokyo 1986; 61–71
   Google Scholar
• Eisenbarth G. S. Type 1 Diabetes Mellitus: a chronic autoimmune disease. N. Engl. J. Med. 1986; 314: 1360–1368
   PubMed Web of Science ®Google Scholar
• Hu Y., Nakagawa Y., Purushotham K. R., Humphreys-Beher M. G. Functional changes in salivary glands of autoimmune disease prone NOD mice. Am. J. Physiol. 1992; 263: E607–E614
   PubMedGoogle Scholar
• Humphreys-Beher M. G., Brinkley L., Purushotham K. R., Wang P. -L., Nakagawa Y., Dusek D., Kerr M., Chegini N., Chan E. K. L. Characterization of antinuclear antibodies present in the scrum from non-obese diabetic (NOD) mice. J. Clin. Immunol. Immunpathol. 1993; 68: 350–356
   PubMedGoogle Scholar
• Humphreys-Beher M. G., Hu Y., Wang P. -L., Purushotham K. R. Utilization of the NOD mouse as an animal model for the study of secondary Sjogren's syndrome. The Lacrimal Gland, Tear Film and Dry Eye Syndromes: Basic Science and Clinical Relevance, D. Sullivan. Plenum Press, New York 1994; Vol 350: 631–636
   Google Scholar
• Fox R. I., Kang H. -I. Pathogenesis of Sjogren's syndrome. Rheumatic Dis. Clin. North Am. 1992; 18: 517–538
   PubMed Web of Science ®Google Scholar
• Vitali C., Bombardicri S., Moutsopoulos H. M., et al. Preliminary criteria for the classification of Sjogren's syndrome: results of a perspective concerted action supported by the European community. Arthritis Rheum. 1993; 36: 340–347
   PubMed Web of Science ®Google Scholar
• Daniels T. E., Fox P. C. Salivary and oral components of Sjogren's syndrome. Rheumatic Dis. Clin. North Am. 1992; 18: 571–589
   PubMed Web of Science ®Google Scholar
• Chan E. K. L., Andrade L. E. C. Antinuclear antibodies in Sjogren's syndrome. Rheumatic Dis. Clin. North Am. 1992; 18: 551–570
   PubMed Web of Science ®Google Scholar
• Johnson B. C., Morton J. I., Trune D. R. Lacrimal and salivary gland inflammation in the C3H/lpr autoimmune strain mouse: A potential model for Sjogren's syndrome. Otolaryngol. Head Neck Surg. 1992; 106: 394–399
   Google Scholar
• Wolff A., Scott J., Woods K., Fox P. C. An investigation of parotid gland function and histopathology in autoimmune disease-prone mice of different age groups. J. Oral Pathol. Med. 1991; 20: 486–489
   PubMed Web of Science ®Google Scholar
• Jonsson R., Tarkowski A., Bäckman K., Holmdahl R., Klareskog L. Sialoadenitis in the MRL-1 mouse: morphological and immunohistochemical characterization of resident and infiltrating cells. Immunol. 1987; 60: 611–616
   PubMed Web of Science ®Google Scholar
• Kessler H. S. A laboratory model for Sjögren's syndrome. Am. J. Pathol. 1968; 52: 671–677
   PubMed Web of Science ®Google Scholar
• Tarkowski A., Jonsson R., Klareskog L. Experimental Sjögren's syndrome: a review. Scand. J. Rheumatol. 1986; 61: 274–279, Suppl.
   Google Scholar
• Hu Y., Purushotham K. R., Wang P. -L., Dawson R., Jr., Humphreys-Beher M. G. Down-regulation of β-adrenergic receptors and signal transduction response in salivary glands of NOD mice. Am. J. Physiol. 1994; 266: G433–G443
   Google Scholar
• Hausdorff W. P., Caron M. G., Lefkowitz R. J. Turning off the signal: desensitization of β-adenergie function. EASEB. J. 1990; 4: 2881–2889
   Google Scholar
• Quissell D. O., Watson E., Dowd F. J. Signal transduction mechanisms involved in salivary gland regulated cxocytisis. Crit. Rev. Oral Biol. Med. 1992; 3: 83–107
   Google Scholar
• Nakagawa Y., Purushotham K. R., Wang P. -L., Fischer J. E., Dunn W. A., Schneyer C. A., Humphreys-Beher M. G. Alterations in the subcellular distribution of p21 ras-GTPase activating protein in proliferating rat acinar cells. Biochem. Biophys. Res. Commun. 1992; 187: 1172–1179
   Google Scholar
• Tate S. S., Meister A. Interaction of γ-glutamyl transpeptidase with amino acids, dipeptides and derivatives and analogs of gluthione. J. Biol. Chem. 1974; 249: 7593–7602
   PubMed Web of Science ®Google Scholar
• Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72: 248–254
   PubMed Web of Science ®Google Scholar
• Hashimoto K., Watanabe Y., Uchida S., Yoshida H. Increase in the amount of adenylate cyclase in rat gastrocnemius muscle after denervation. Life Sci. 1989; 44: 1887–1895
   PubMedGoogle Scholar
• Nakagawa Y., Gammichia J., Purushotham K. R., Schneyer C. A., Humphreys-Beher M. G. Epidermal growth factor activation of rat parotid gland adenylate cyclase and mediation by a GTP-binding regulatory protein. Biochem. Pharmacol. 1991; 42: 2333–2340
   Google Scholar
• Gilman A. G. A protein binding assay for adenosine 3′:5′-cyclic monophosphate. Proc. Natl Acad. Sci. USA 1970; 67: 305–312
   PubMed Web of Science ®Google Scholar
• Levitzki A. From epinephrine to cycle AMP. Science 1988; 241: 800–806
   PubMed Web of Science ®Google Scholar
• Sibley D. R., Benovie J. L., Caron M. G., Lefkowitz R. J. Regulation of transmembrane signalling by receptor phosphorylation. Cell. 1987; 48: 913–922
   PubMed Web of Science ®Google Scholar